214 related articles for article (PubMed ID: 11919393)
61. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
Ross TS; Bernard OA; Berger R; Gilliland DG
Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
[TBL] [Abstract][Full Text] [Related]
62. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N; George TI; Gotlib J
Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
[TBL] [Abstract][Full Text] [Related]
63. Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB-NDE1 fusion.
Cavazzini F; Bardi A; Ciccone M; Rigolin GM; Gorello P; La Starza R; Mecucci C; Cuneo A
Cancer Genet Cytogenet; 2009 Oct; 194(1):67-9. PubMed ID: 19737658
[No Abstract] [Full Text] [Related]
64. A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate.
Wittman B; Horan J; Baxter J; Goldberg J; Felgar R; Baylor E; Cromwell B; Cross N; Bennett JM
Leuk Res; 2004 May; 28 Suppl 1():S65-9. PubMed ID: 15036944
[TBL] [Abstract][Full Text] [Related]
65. TV6 and PDGFRB: a license to fuse.
Lierman E; Cools J
Haematologica; 2007 Feb; 92(2):145-7. PubMed ID: 17296561
[No Abstract] [Full Text] [Related]
66. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
Iriyama N; Takahashi H; Naruse H; Miura K; Uchino Y; Nakagawa M; Iizuka K; Hamada T; Hatta Y; Nakayama T; Takei M
Mol Genet Genomic Med; 2019 Apr; 7(4):e00591. PubMed ID: 30697976
[TBL] [Abstract][Full Text] [Related]
67. Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.
Costa D; Muñoz C; Carrió A; Nomdedeu M; Calvo X; Solé F; Luño E; Cervera J; Vallespí T; Berneaga D; Gómez C; Arias A; Such E; Sanz G; Grau J; Insunza A; Calasanz MJ; Ardañaz MT; Hernández JM; Azaceta G; Álvarez S; Sánchez J; Martín ML; Bargay J; Gómez V; Cervero CJ; Allegue MJ; Collado R; Campo E; Nomdedeu B;
Genes Chromosomes Cancer; 2013 Aug; 52(8):753-63. PubMed ID: 23686965
[TBL] [Abstract][Full Text] [Related]
68. Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.
Jawhar M; Naumann N; Knut M; Score J; Ghazzawi M; Schneider B; Kreuzer KA; Hallek M; Drexler HG; Chacko J; Wallis L; Fabarius A; Metzgeroth G; Hofmann WK; Chase A; Tapper W; Reiter A; Cross NCP
Leukemia; 2017 Oct; 31(10):2271-2273. PubMed ID: 28751768
[No Abstract] [Full Text] [Related]
69. t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia.
Wessels JW; Fibbe WE; van der Keur D; Landegent JE; van der Plas DC; den Ottolander GJ; Roozendaal KJ; Beverstock GC
Cancer Genet Cytogenet; 1993 Jan; 65(1):7-11. PubMed ID: 8431918
[TBL] [Abstract][Full Text] [Related]
70. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
71. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
Crescenzi B; La Starza R; Nozzoli C; Ciolli S; Matteucci C; Romoli S; Rigacci L; Gorello P; Bosi A; Martelli MF; Marynen P; Mecucci C
Cancer Genet Cytogenet; 2007 Jul; 176(1):67-71. PubMed ID: 17574967
[TBL] [Abstract][Full Text] [Related]
72. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.
Erben P; Gosenca D; Müller MC; Reinhard J; Score J; Del Valle F; Walz C; Mix J; Metzgeroth G; Ernst T; Haferlach C; Cross NC; Hochhaus A; Reiter A
Haematologica; 2010 May; 95(5):738-44. PubMed ID: 20107158
[TBL] [Abstract][Full Text] [Related]
73. [Molecular bases of leukemia, MPD and MDS].
Kitamura T
Rinsho Ketsueki; 2009 Mar; 50(3):174-81. PubMed ID: 19352084
[No Abstract] [Full Text] [Related]
74. Reciprocal translocation involving 3q21 in an unusual myeloproliferative disorder with myelodysplastic features and prominent dysmegakaryopoiesis.
Cedrone M; Mecucci C; Burgio VL; Diverio D; Petti MC; Alimena G
Cancer Genet Cytogenet; 1991 Jan; 51(1):73-8. PubMed ID: 1984850
[TBL] [Abstract][Full Text] [Related]
75. Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms.
Fang H; Tang G; Loghavi S; Greipp P; Wang W; Verstovsek S; Medeiros LJ; Reichard KK; Miranda RN; Wang SA
Histopathology; 2020 Jun; 76(7):1042-1054. PubMed ID: 32083752
[TBL] [Abstract][Full Text] [Related]
76. The second international congress on myeloproliferative and myelodysplastic syndromes.
Silver RT; Bennett JM; Deininger M; Feldman E; Rafii S; Silverstein RL; Solberg LA; Spivak JL
Leuk Res; 2004 Sep; 28(9):979-85. PubMed ID: 15234576
[TBL] [Abstract][Full Text] [Related]
77. [Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of PDGFRB due to t (5;14)(q33;q22)].
Fujii T; Ohno N; Matsui T; Kitahara S; Kobayashi S; Sahara N; Sakamoto N; Matsunaga T
Rinsho Ketsueki; 2021; 62(11):1635-1638. PubMed ID: 34866089
[TBL] [Abstract][Full Text] [Related]
78. Involvement of chromosomes 4, 11, and 17 in a case of myelodysplastic syndrome.
Ohyashiki K; Yoshida MA; Ohyashiki J; Kiyokawa M; Tsurumi N; Katsunuma H; Sandberg AA
Cancer Genet Cytogenet; 1985 Nov; 18(3):265-73. PubMed ID: 3863700
[TBL] [Abstract][Full Text] [Related]
79. [Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities].
Liu Q; Xu W; Zhu Y; Fan L; Qiu HR; Wang R; Qiao C; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1257-60. PubMed ID: 19099622
[TBL] [Abstract][Full Text] [Related]
80. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
Bain BJ
Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
